Delivery Order SPE2DB22D3501-SPE2DB25FWP01
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count), with a ceiling value of $1,838.08 and a firm fixed price structure. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance and serves as the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,859.42 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. This firm fixed-price, non-competitive set-aside contract was executed on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same city....
- The Defense Logistics Agency awarded a delivery order valued at $1,420.47 to AmerisourceBergen Drug Corp for 90 tablets of Meloxicam 15 mg, with a completion date of February 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 15 mg meloxicam tablets. The order, valued at $7,916.30, is part of an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a maximum value of $999,999,999 through December 2025. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Meloxicam 15 mg tablet units (100 count) valued at $1,149.80 on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Meloxicam is a nonsteroidal anti-inflammatory drug commonly used in military and...
- This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,184.65 firm-fixed-price contract is for the delivery of 4,565,190,789 units of Meloxicam 7.5 mg tablets in 90-count packages. The contract has a completion date of July 19, 2024 and was awarded on July 18, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide...
- This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award, with ID SPE2DB24D2105|SPE2DB25FAPKF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $83,795.68, is a delivery order for 4,567,669,334 units of the prescription drug Meloxicam 15 mg tablet. The contract has a completion date of March 24, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWP01Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,117.29 to AmerisourceBergen Drug Corp for the supply of Meloxicam 15 mg tablets in unit dose packaging (100s). This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical distribution hub for federal pharmaceutical procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs. The Meloxicam delivery order represents a routine pharmaceutical supply transaction supporting the Defense Health Agency and other federal healthcare systems, reflecting AmerisourceBergen's role as a primary pharmaceutical vendor for defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/24/25 |